CDC Updates COVID-19, Influenza Vaccine Recommendations for 2024-2025 Respiratory Virus SeasonJennings, SydneyPatient Care (Online)
the advisory group agreed thatFluMist Quadrivalent(MedImmune) — the only live attenuated influenza vaccine approved by the US Food and Drug Administration (FDA) — not be administered in the 2017-2018 season, owing to a decline in efficacy. ACIP ...
During the 2023 flu season in these same countries, thevaccine efficacyagainst hospitalizations due to the flu was estimated to be about 52 percent. The new data was based on influenza cases that occurred between March and July of this year. The report noted the vaccine still “significantly lo...
Why did the CDC lie about vaccine efficacy, incorrectly calling it a "pandemic of the unvaccinated" (July 16, 2021) — using mostly January/February 2021 unweighted data when over 98% of total Americans were still unvaccinated? BREAKING NEWS: The CDC is not releasing the detailed breakthrough...
Why did the CDC lie about vaccine efficacy, incorrectly calling it a "pandemic of the unvaccinated" (July 16, 2021) — using mostly January/February 2021 unweighted data when over 98% of total Americans were still unvaccinated? BREAKING NEWS: The CDC is not releasing the detailed breakthrough...
CDC Infectious Diseases Over 60s get long-term protection against RSV from single shot A three-year study has found robust evidence that one vaccine for respiratory syncytial virus offers older adults long-term protection, even if efficacy wanes. Despite this, just one dose cut serious illness...
2, researchers determined that the flu vaccine has been 47 percent effective overall against influenza illness. The findings were included in a report published Thursday. "CDC recommends that health care providers continue to administer influenza vaccine because influenza activity is ongoing and the...
The 2024–25 seasonal influenza vaccine doesn’t prevent H5N1 bird flu but could play a pivotal role in preventing a pandemic, the CDC says.
and those aged 25 years or older with underlying conditions that put them at high risk of complications from influenza should be at the front of the line when a vaccine for the currently circulating novel H1N1 influenza virus becomes available, according to advisors to the US Centers for Disease...
It comes as cases of influenza and respiratory syncytial virus, or RSV, continue rising. The viruses typically spread during winter, but experts have said the surges are occurring earlier than usual. A person gets an influenza vaccine from a pharmacist du...